ABSTRACT Gene set analysis using signaling pathway has become a popular downstream analysis following differential expression analysis. From a biological point of view, only some portions of a pathway are expected to be altered; however, a few approaches using the different importance of genes in signaling pathways, which encompass the constitutive functional nonequivalent roles of genes in real pathways, have been proposed and none of them tries to associate the importance of genes with the related disease. In this paper, we developed an extended method of signaling pathway impact analysis (SPIA), called gwSPIA, by incorporating three signaling pathway-based gene weight merits that reflect the importance of genes from different aspects and attempt to associate the importance of genes with the related diseases. By applying the gwSPIA to the gene expression data sets in comparison with other seven methods in three measures, sensitivity, prioritization, and specificity, we show that the gwSPIA ranks in the second place in both sensitivity and prioritization. Furthermore, the specificity of the gwSPIA is better than SPIA, which is lower than 25%. The results also suggest that the gene weight used in the gwSPIA can reflect the association between the genes and the related diseases. The R package of the gwSPIA can be accessed from https://github.com/sterding/gwSPIA.
I. INTRODUCTION
As the rapid development of high-throughput sequencing technology in recent years, more and more differentially expressed genes (DEGs) studies have been proposed to reveal the perturbed signaling pathways across different disease conditions, drug treatments, or developmental stages. The analysis that combines DEGs with signaling pathways has become a dominant analytical method. In such an analysis, significant signaling pathways based on DEGs are identified using statistical methods, allowing researchers and clinicians to better understand interactions between diseases and genes. Common signaling pathway databases include Kyoto Encyclopedia of Genes and Genomes (KEGG) [1] - [3] , BioCarta [4] , [5] , and Reactome [6] , [7] . The original signaling pathway analysis methods can be divided into two categories: pathway-topology based and non-pathwaytopology based approaches.
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Most classic signaling pathway analysis methods in the non-pathway-topology based category are designed based on either over-representation analysis (ORA) or functional class scoring (FCS). ORA-based methods, including OntoExpress [8] , [9] and Gene Ontology Enrichment Analysis Software Toolkit (GOEASE) [10] , merely measure the number of differential expressed genes in a specific signaling pathway and determine the significance of overlapping via statistical tests like Fisher's exact test. FCS-based methods however take into account of coordinated changes of genes expression in the specific signaling pathways, such as gene set enrichment analysis (GSEA) [11] . All these methods have common limitations that genes in a signaling pathway are treated equally, and they are without considering the complex interactions between genes.
On the other hand, pathway-topology based approaches consider the complex interaction between genes through incorporating pathway topology information, specifically the KEGG signaling pathways. SPIA is a classic pathwaytopology based approach, which combines the features of ORA or FCS method and the perturbation on a given signaling pathway [12] . Later, Li et al. improved the SPIA method by using a subgraph method to increase the accuracy of SPIA [13] . Bao et al. recently improved the SPIA by substituting +1 or −1 as the strength of interaction of genes with Pearson correlation coefficients and mutual information to increase the accuracy of SPIA [14] . Gene Graph Enrichment Analysis (GGEA) is another method to detect gene sets enriched consistently and coherently, based on prior knowledge derived from directed gene regulatory networks [15] . Ihnatova et al. developed a novel R package that offers seven distinct methods for topology-based pathway analysis [16] . Liu et al. proposed a topological method to find sub signaling pathways in a signaling pathway to improve the performance of pathway analysis method [17] . However, all these pathway topology-based methods still have the limitation of treating the functional roles of genes in pathways equivalently. Because genes in pathways can function inequivalently, they could have different importance in signaling pathways in different disease.
Apparently, some genes are more important than others are, if they are in a hub position in the pathway (or network) topology or have a key functional role in different disease process biology. There are existing methods weighing the importance of genes. And these methods are called gene-weight-based methods. For example, EnrichNet measures the functional association between the gene list of interest and a functional gene set using the Random Walk with Restart (RWR) algorithm [18] . Pathway Analysis with Down-weighting of Overlapping Genes (PADOG) uses the frequency of a gene present in the pathways analyzed to improve gene set analysis [19] . Functional Link Enrichment of Gene Ontology or gene sets (LEGO) takes into consideration these two types of information by incorporating network-based gene weights in ORA analysis [20] . However, methods like EnrichNet, PADOG or, LEGO are all based on the non-pathway-topology based method, not based on pathway topology. Thus, like any other non-pathway-topology based methods, these methods do not consider the complex interactions between genes in pathways. Moreover, the gene weights used by them are fixed values for different diseases. These weights cannot reflect the association between genes and diseases.
In this study, we developed an extended method of SPIA, called gwSPIA, by considering both the pathway topology (i.e. the interactions between genes in pathways) and the importance of genes. This method is a gene weight method, but not like the methods mentioned above this method is improved from a pathway-topology based method. It enhanced SPIA by weighing genes with various signaling pathway-based merits. Thus, gwSPIA has two advantages: on one hand, it takes the complex interactions in consideration; on the other hand, it also takes the importance of gene which can reflect the association between genes and diseases in consideration. Three types of weights are used in gwSPIA: impact factor (IF), betweenness centrality (BC), and specificity (SP). We increased the accuracy of SPIA by incorporating these weights into the SPIA method. In addition, we can analyze the relationship strength of differential expressed genes and specific phenotypes based on IF and SP. The IF value can vary a lot for different diseases which can reflect the association between genes and diseases. We applied the new method gwSPIA to 33 data sets. All these data sets are picked up based on specific disease pathways. For example, we aim for the colorectal cancer pathway as the target pathway in colorectal cancer data set. As an extended version of SPIA, we compare gwSPIA with SPIA and other 6 methods from three aspects: sensitivity, prioritization, and specificity. Results show that the performance of gwSPIA is always ranked in the second place in terms of comparing both sensitivity and prioritization compared with other methods. And our results demonstrate the efficacy of the gene weights used in this study.
II. METHODS

A. BENCHMARK DATA
A total 33 datasets from the KEGGdzPathwaysGEO R-package and KEGGandMetacoreDzPathwaysGEO R-packages are used as benchmark data (see Table 1 ) [19] , [21] , including various cancers and neurological diseases. These disease datasets are analyzed in the same way: First, for the probes with the same Entrez gene ID, only the probes with the highest average expression can be retained. Second, differential expression analysis is performed by fitting linear models using the empirical Bayes method as implemented in the limma R-package [22] . Each of the 33 datasets was matched with the corresponding KEGG pathway according to its name, e.g. a dataset of colorectal cancer patients is associated with the colorectal cancer pathway [23] . We call such a pathway a target pathway and its p-value and rank in the database are further evaluated. We use the following rules to identify DEGs: i) selecting more than 200 genes with FDR adjusted p-values < 0.1; ii) if not, selecting more than 200 genes with original p-values < 0.05 and log (fold change)> 1.5; iii) if not, selecting top 1% of genes ranked by p-values.
B. PATHWAYS IN KEGG DATABASE
The signaling pathways are downloaded in the KEGG. In the KEGG database, each pathway stores in an XML document (KGML format). For our method, we analyze 213 signaling pathways downloaded from the KEGG database one by one. The pathways can be transformed into networks format using KEGGgraph R-package, where genes and their interactions are nodes and edges respectively [50] . The igraph R-package is used to combine the 213 gene networks into one big gene network [51] .
C. SIGNIFICANTLY ENRICHED PATHWAYS ANALYSIS
The procedure to identify significantly enriched pathways using gwSPIA include: (i) reconstructing the gene network from the signaling pathways using KEGGgraph R-package, (ii) calculating the gene weights including SP and BC from these gene networks, (iii) reconstructing the all signaling pathways into a big gene network by the genes shared in different pathways through R package igraph, (iv) projecting the DEGs onto the networks of the constructed gene networks, (v) calculating the gene weight IF based on the big gene network, and (vi) evaluating the statistical significance of each pathway. gwSPIA is implemented by using the statistical programming language R. The flow can be seen in Figure 1 . expressed genes linked to the gene downstream directly. If the value which reflects the DEGs of the genes in the direct downstream place of a gene is bigger, we think that the gene is tended to be an important gene which may lead to the different expression of the DEGs downstream directly. Thus, the bigger IF is, the more important the gene is. The IF is an up-weighting value. Furthermore, the IF value is variational in different datasets and can reflect the association between gene importance and related diseases. In graph theory, BC is a measure of centrality in a graph based on shortest paths. Here we define BC of a gene as the number of shortest paths across it between two any genes in a given signaling pathway. The more the shortest paths cross a gene in a signaling pathway, the more important the gene is. For example, in the Ras signaling pathway, Ras is included in much more shortest paths than other genes in the pathway so changing expression of gene Ras might have a bigger impact on the expression of the pathway. And SP of a gene is the number of times of the gene that appears in all signaling pathways analyzed. The genes with lower SP might more important than other genes. This is just like the sight words in English [19] . Thus, the SP value is a down-weighting value [19] .
Given P networks with G genes in these networks, we calculate the gene weights of each gene in the P networks. Here, for each gene G i in P j network, we compute its BC value as the numbers of liner paths across G i using igraph R package. The bigger the BC value, the more important a gene is. If the BC values in the network P j have s levels, and the BC value of the gene G i in the network P j at k level, then the BC value was normalized in such a way:
We compute the SP from all 182 signaling pathways. The SP value of a gene G i is the frequency of the gene appearing in all 182 signaling pathways. Before calculating the IF value of genes, we use the R package igraph to reconstruct the 182 signaling pathways into a big gene network. The IF value of a gene is defined as the number of differential expressed genes linked with the gene in the downstream. Thus, the IF value of a gene is ranged from 0 to the out-degree of the gene.
We think that the IF value is associated with the SP value. The larger the frequency of a gene appearing in the pathways analyzed is, the bigger out-degree the gene is supported to have in the big gene network contents all signaling pathways analyzed. The IF value of a gene is calculated from the outdegree of the gene. So the IF value may be influenced by the SP value. So to eliminate the effects of SP value to IF value, we calculate the weight of the gene from IF and SP value in such way:
The w I is an up-weighting value. The bigger w I of a gene is, the more important the gene is. The w I can vary in a large range. Thus, we use the Min-Max normalization to normalize the gene weight w I using the formula:
E. SIGNALING PATHWAY IMPACT ANALYSIS BY INCORPORATING SIGNALING PATHWAY-BASED GENE WEIGHTS (gwSPIA)
gwSPIA method combines the over-representation of pathways and the abnormal perturbation in a given pathway in the same way with the SPIA method [12] . These two aspects are captured by two independent probability values, P FCS and P PERT . P FCS captures the significance of the given pathway by a method improved from the PADOG method [19] . P FCS is the probability to observe an average t-score in a given pathway, S per , more extreme than S obs just by chance. The t-score of a gene is calculated using R package limma. The average t-score of a given pathway P j is calculated in this way:
In Equation (4), T (g i ) dominate the t-score of a gene g i in the given pathway P j , w n (g i ) represent the weight w n of the gene g i . N P j is the number of genes in the given pathway P j . Different from the original PADOG method, we multiply the T (g i ) with the gene weight w n (g i ) instead of the normalized frequency of the gene g i across all gene sets to be analyzed to improve the accuracy. When computing the random score S per for the same pathway, we randomly select N P j t-scores from the t-scores of all genes analyzed. Then S per is computed for nB=2000 times, so
is computed in such way:
Because the t-score and the combined gene weight of a gene are all independent of fold change, the modified PADOG can be used to replace the original ORA method used in SPIA.
The probability P PERT is measured by propagating measured expression changes across the pathway topology and is calculated based on the amount of perturbation of genes. Formulate of calculating the perturbation of each gene (perturbation factor) is as follow:
Differ from the SPIA method, the first term represents that the signed normalized measured expression change of the gene g i (log fold-change if two conditions are compared) multiply with the normalized BC value of the gene. The second term in Equation (6) is the sum of perturbation factors of the genes g m directly upstream of the target gene g i , normalized by the number of downstream genes of each such gene N ds (g m ) . The absolute value of β im quantifies the strength of the interaction between genes g i and g j . And in this method, the β im is always set as 1. Just like SPIA, gwSPIA calculates the net perturbation accumulation at the level of each gene, Acc g j , as the difference between the perturbation factor PF of a gene and its observed weighted log fold-change:
The total net accumulated perturbation in the pathway is computed as t A = Acc (g i ). Then the second probability, P PERT , will be the probability to observe a total accumulated perturbation of the pathway, T A , more extreme than t A just by chance:
Then gwSPIA defines a significance evaluation index P G in the same way with SPIA, which is calculated by the following formula:
In the formula (9), c = P OVER × P PERT . When there are more than one gene sets for analysis, we use Bonferroni procedure to adjust the p-value [52] . We also report the adjusted p-value based on FDR [53] . Actually, the two weights can be used to improve other methods. Because in the calculation of the perturbation factor of a gene, N ds which is the number of downstream genes of such gene is used. If we use the weight w I to improve the PF, the function of N ds and w I will be repetitive. VOLUME 7, 2019
F. SEVEN OTHER METHODS APPLIED TO COMPARE WITH gwSPIA
Since gwSPIA is like an enhanced version of SPIA with gene weight considered, we first compare gwSPIA with the SPIA method. Fisher [54] , GSA [55] , and GSEA [11] are three classic pathway analysis methods. Then Fisher, GSA, and GSEA method are also compared with gwSPIA. MRGSE and ROntoTools are also compared with gwSPIA. In the end, the gene-weight-based method PADOG is also compared with gwSPIA.
( whether the genes in a particular gene set have coordinated changes [55] . We used the function ''GSA'' of the GSA package in R. (4) GSEA: Gene Set Enrichment Analysis, frequently used and widely accepted method, a Kolmogorov-Smirnov statistic was used to test whether the rank of the p-value of a gene in a genome was similar to a uniform distribution [11] . The GSEA is implemented as the default set-based enrichment method of the EnrichmentBrowser [56] R package. (5) MRGSE: tests if the ranks in a particular gene set (sorted by the t-statistics) are different from genes in the background gene list [57] . We use moderated t-test in ''limma'' package in R to calculate t values and ''geneSetTest'' function in ''limma'' package for ranking of enriched gene sets. (6) ROntoTools: Pathway-Express in ROntoTools incorporates pathways topology to calculate a global probability for genes in a given pathway. The negative log value of this global probability is defined as the impact factor of a gene, and the impact factor values are then used for pathway enrichment analysis [12] , [58] . This method is contained in the R package ''ROntoTools'' and the function ''pe'' was used. (7) PADOG: the method computes a gene set score as the mean of absolute values of weighted moderated gene t-scores. The gene weights are chosen to favor genes appearing in few pathways versus genes that appear in many pathways [19] . We use the R package PADOG to analyze the data sets.
G. THE MEASURES OF SENSITIVITY, PRIORITIZATION, AND SPECIFICITY
Michaela et al. compiled many disease gene expression datasets whose KEGG target pathways were known [23] using a number of measures to evaluate the performance of different methods. We also follow these measures in the benchmark, which are including sensitivity, prioritization, and specificity. The sensitivity of a method is the median p-values of the target pathways in 33 datasets, with a lower p-value indicates higher sensitivity.
In each dataset, all tested pathways are sorted by their p-value from lowest to highest. The rank percentage of the target pathway is the ratio of the rank of target pathway and the number of pathways analyzed (213 pathways in this study). The prioritization of a method is the median rank percentage of the target pathways in 33 datasets with lower rank percentages indicates higher prioritization. The specificity of a method is the ratio of significant pathways (using a significance threshold of 0.05) in the pathways analyzed.
III. RESULTS
In 2015, Michaela et al. compiled 36 disease gene expression datasets in which the target pathway of each dataset was known [23] . They used these datasets to compare 7 FCS methods. 33 datasets of 36 can acquire the results of target pathways using all 8 methods compared in this article. Thus, here, to further test the usefulness of gwSPIA in functional studies, we select 33 datasets as the benchmark. And we compare gwSPIA with SPIA, Fisher, GSA, GSEA, MRGSE, ROntoTools, and PADOG. The descriptions of these methods can be found in Methods. We follow the instructions of their respective R package to perform pathway enrichment. The usefulness of these gene weights used in this article is also proved in this section.
A. COMPARISON OF gwSPIA WITH SEVEN METHODS USING A BENCHMARK OF 33 DISEASE GENE EXPRESSION DATASETS
In total 33 gene expression datasets are used to compare gwSPIA with seven other methods. Every dataset represents a certain disease and has been linked to a defined target pathway from the KEGG database (see Table 1 ). Michaela et al. proposed measures to test the performance of a method, which are sensitivity (defined as the p-value of the target pathway), prioritization (defined as the rank percentage for the target pathway), and specificity (defined as the average percentage of pathways detected as significant and not significant). Out of all eight methods being compared, gwSPIA ranks in second place in terms of sensitivity (the median p-value of the target pathways in 33 datasets) (Figure 2 ). And gwSPIA also ranks in second place in terms of prioritization (the median rank for target pathways in 33 datasets) (Figure 3) . It is worth noting that the sensitivity measure and the prioritization measure evaluate the performance of a method from different aspects, and a method that ranks in first place based on a measure may not also rank in first place based on another measure. For instance, PADOG ranks in first place in terms of prioritization, while it ranks in fourth place in terms of sensitivity. MRGSE ranks in first place in terms of sensitivity, but it only ranks in sixth place in terms of prioritization. gwSPIA ranks in second place in both sensitivity and prioritization, suggesting that it is able to prioritize target pathways with high sensitivity. For the specificity of the eight methods, we can note that MRGSE identifies on average almost 50% of all database pathways as significantly enriched, while for GSA it is lower than 10% of the significant pathways (Figure 4 ). For SPIA, Fisher, and gwSPIA can identify between 20% and 35% of the significant pathways. This can demonstrate that the gwSPIA may have a similar specificity to SPIA and Fisher. For MRGSE, depending on disease, multiple pathways could be altered. However, it could be questioned whether such a number of pathways is realistic or it reflects the lack of specificity of this method [23] . For GSA, depending on disease, few pathways could be altered. This method also lacks specificity. It can infer that the specificity of gwSPIA is modest. In conclusion, the performance of gwSPIA in this benchmark well illustrates its usefulness. And this result also suggests that the use of gene weights in gwSPIA can improve the performance of SPIA. In addition, the computational efficiency of gwSPIA is similar to SPIA. This is because that gwSPIA is an extended method of SPIA.
B. DEGs ANALYSIS THROUGH THE GENE WEIGHT COMBINE IF AND SP IN TWO BENCHMARKS
In this paper, we calculate a gene weight w I that combines IF and SP. The genes with high w I are thought highly associated with the specific phenotype and vice versa. In this section, we analyze the top 10 DEGs ranked through the combined gene weight w I of 2 benchmark data sets from largest to smallest, respectively. The 2 benchmark data sets are GSE4107 and GSE4183 as two examples. And we also analyze the 10 DEGs ranked in the end by the weight w I from largest to smallest. All these genes can be seen in Table 2 .
In the benchmark data set GSE4107, genes SFRP2, SFRP1, PRNP, NFE2L2, and WWTR1 which are ranked in the first play important roles in colorectal cancer shown in MalaCards dataset). Gene SFRP5 is an important paralog of SFRP1. Genes SFRP2, SFRP1, SFRP4, and SFRP5 are in the same node in the wnt signaling pathway. The wnt signaling pathway is highly associated with colorectal cancer [59] . Gene PARVB is in the Focal adhesion pathway which also plays an important role in colorectal cancer [60] . Gene KIF3A only participates in the Hedgehog signaling pathway which is also highly associated with colorectal cancer [61] . The gene PRPH has no association with colorectal cancer. This may come from the noise of the data. These genes are the top 10 genes ranked by the weight from the largest to smallest. Genes MCU, SLC27A2, STEAP1, GPX7, MAN1C1, SLC30A1, PCGF5 and ENTPD1 are not associated with colorectal cancer as the MalaCards data set show. CD46 and AQP8 are associated with colorectal cancer. Gene CD46 participates in Complement and coagulation cascades pathway and Measles which have no relationship with colorectal cancer. Gene AQP8 is in the most downstream of the Bile secretion pathway. Thus, there is no gene in the downstream of gene AQP8. These genes are the last 10 genes ranked by the weight from the largest to smallest.
In the benchmark data set GSE4183, genes YAP1, WWTR1, TEAD1, and AJUBA are highly associated with colorectal cancer shown in the MalaCards data set. An important paralog of gene LATS2 is LATS1. From the MalaCards data set, we can find that LATS1 is associated with colorectal cancer. And LATS2 participates in the Hippo signaling pathway which is highly associated with colorectal cancer [62] . COL6A3 may be a promising biomarker or target for the prognosis and treatment of CRC [63] . An important paralog of ROBO3 is ROBO2. From the MalaCards data set, we can find that ROBO2 is associated with colorectal cancer.
ROBO3 appears in the Axon guidance pathway. The Axon guidance pathway plays an important role in colorectal cancer [64] . FST is in the upstream of the TGF-beta signaling pathway which is also an important pathway for colorectal cancer [65] . AGAP2 is also in the upstream of the FoxO signaling pathway and participates in the Endocytosis pathway. The two pathways are both highly related to colorectal cancer [66] , [67] . These genes are the top 10 genes ranked by the weight from the largest to smallest. The genes WDR61, SPIRE2, CELA3B, NPFFR1, SPTLC2, DERL2, CLIP1, SLC5A1, and AMOTL1 have no association with colorectal cancer and are ranked in the last 10 by the weight from the largest to smallest. TRPM6 is highly associated with colorectal cancer. However, this gene is a gene with no genes in the downstream.
From the analysis of genes with weight w I in the two benchmark data sets, we can see that the DEGs with high w I are supposed to highly associate with a specific phenotype. The DEGs with low w I always have no association with specific phenotypes.
C. THE USEFULNESS OF THE COMBINED GENE WEIGHT
We enrich the genes which ranked in the top 500 by the value of gene weight w I ranked from high to low. The result showed that 25 signaling pathways are enriched more than 10 genes using 5 colorectal cancer datasets of 33 benchmark ( Figure 5 ). Most of these pathways are highly associated with colorectal cancer according to scientific articles. The pathway Chemical carcinogenesis is highly associated with colorectal cancer [68] . Phosphatidylinositol 3-Kinase is important in the management of metastatic colorectal cancer [69] . Thus, the signaling pathway Phosphatidylinositol signaling system may associate with colorectal cancer. Obviously, pathway MicroRNAs in cancer is highly associated with cancer. The Jak-STAT signaling pathway is a biological target with therapeutic implications [70] . The proliferation and migration of colorectal cancer cells can be inhibited by the inhibition of cytokine receptors [71] . Thus, pathway Cytokine-cytokine receptor interaction may associate with colorectal cancer. SLIT2 axon guidance can suppress the growth of colorectal cancer cells [72] . It indicates that the Axon guidance pathway is related to colorectal cancer. HOXA3 promotes tumor growth of human colorectal cancer through activating the Ras signaling pathway [73] . The pathway Endocytosis obviously plays an important role in colorectal cancer [74] . Focal adhesion, Pathways in cancer, Cell cycle, ECM-receptor interaction, MAPK signaling pathway, PI3K-Akt signaling pathway, Choline metabolism in cancer, Phospholipase D signaling pathway, Wnt signaling pathway, and RNA transport are highly associated with cancer including colorectal cancer [75] - [80] . Activated thyroid hormone promotes differentiation and chemotherapeutic sensitization of colorectal cancer stem cells [81] . So the Thyroid hormone signaling pathway is related to colorectal cancer. RASAL2 promotes tumor progression through the LATS2/YAP1 axis of Hippo signaling pathway in colorectal cancer [82] . For the Rap1 signaling pathway, Rap1B is a target of miR-139 to suppress human colorectal cancer cell proliferation [83] . Chemokine signaling pathway plays an important role in hepatic metastasis of colorectal cancer [84] . Pathways like Protein digestion and absorption and Amoebiasis are not associated with colorectal cancer. Thus, they only enriched more than 10 genes in GSE4183.
The percentages of the 500 genes detected as different expression and not different expression in 5 colorectal cancer datasets are also shown in the results (Figure 6 ). The results show that most of the top 500 genes are not DEGs in the 5 colorectal cancer datasets. And it is worth noting that the pathways enriched more than 10 genes are mostly associated VOLUME 7, 2019 with colorectal cancer. In conclusion, the combined gene weight used in this study is useful.
D. BC VALUES OF GENES IN PATHWAYS
The genes in a signaling pathway with high betweenness centrality always play roles as switches in the signaling pathways, such as Ras in the Ras signaling pathway. From the Ras signaling pathway in the KEGG data set, we can see that Ras is in the key position on the Ras signaling pathway. And the BC value of node Ras in the pathway is 112, which is the highest. Rap1 in the Rap1 signaling pathway also plays an important role. The BC value of node Rap1 in the pathway is 196 which is also the highest. In the Notch signaling pathway, the BC value of node Notch is 51 which is the second largest in the pathway. The highest BC value in this pathway is 52. PI3K-Akt signaling pathway contains a node named AKT with BC value 366 which is the highest in the pathway. All these nodes in these pathways are very important. The pathways are named by these nodes. Thus, we consider that the genes in a pathway with high BC values play important roles in the pathway.
IV. DISCUSSION
The major limitations of traditional non-pathway-topology based methods are that they ignore the functional nonequivalence roles of genes and the complex interactions between genes. And the major limitation of pathwaytopology based methods is that they ignore the functional non-equivalence roles of genes. Gene weight dominated the importance of genes that collect the information of the functional non-equivalence roles of genes from the pathways can be used to overview the common limitation of non-pathwaytopology based methods and pathway-topology based methods as mentioned above. In fact, methods incorporated the functional non-equivalence roles of genes are presented by some studies in recent years. For instance, EnrichNet measures the functional association between the interesting gene list and a gene set using a Random Walk with Restart (RWR) algorithm [18] . PADOG uses the value that the frequency of a gene appears in pathways analyzed to improve gene set analysis [19] . However, these methods do not consider the complex interactions between genes. These methods only incorporate gene weights with non-pathway-topology based methods. And the gene weight used in these methods cannot reflect the association between genes' importance and disease. Therefore, we propose a new method combined the pathway-based weights of genes IF, SP and BC with a pathway-topology based method SPIA, called gwSPIA. For evaluating our method is applied to 33 differentially expressed gene datasets.
To test the performance of gwSPIA, we compare gwSPIA with original SPIA and other 6 methods in three aspects: sensitivity, prioritization, and specificity following Michaela et al. proposed in 2015. Results show that gwSPIA always ranks in the top compared with the other 7 methods in terms of sensitivity and prioritization. And the specificity of gwSPIA is similar to SPIA and Fisher. Thus, the gene weight used in gwSPIA can help to improve the performance of SPIA.
The method gwSPIA is a gene-weight-based method. The gene weight used in gwSPIA can not only help to improve the performance of SPIA but also can help users to filter DEGs. In this study, the gene weights w I which combined IF and SP value can help to filter DEGs. Two colorectal cancer data sets are used to illustrate the ability of gene weights w I . The DEGs with high w I are supposed to highly associate with a specific phenotype. And the DEGs with low w I always have no association with specific phenotypes. We also enrich the genes which ranked in the top 500 by the value of gene weight ranked from high to low using the data from the 5 colorectal cancer datasets. The result showed that the combined gene weight w I can also be used in the genes which are not DEGs. And the genes in a given pathway with high BC values are supposed to play important roles in the given pathway. These results all dominate the usefulness of the gene weights used in this article.
However, the gene weights IF, SP and BC cannot completely explain the importance of genes in pathways. The IF value is calculated from the DEGs in specific data sets. Thus, the redundancy of data sets can also influence the IF value. And the genes at the end of the network which contain all signaling pathways in the analysis do not all have high association with specific phenotypes. However, the IF values of these genes are zero. Weights that can completely explain the importance of genes in pathways need to be excavated to improve the limitation of proposed methods. Thus, some pathways are not associated with colorectal cancer when enriching the top 500 genes. Nevertheless, the results of gwSPIA and the analysis of gene weights in gwSPIA already make gwSPIA a useful method for large-scale functional genomics studies. In the further, we may use a gene weight to quantify the importance of a gene in the aspect that the number of articles which report the gene is associated with a specific disease. We think that this gene weight can overcome the limitation of the weight used in this article.
V. CONCLUSION
In this study, we developed a new method based on signaling pathway impact analysis combined with consideration of the importance of genes. And we show that this method outperforms better than SPIA and popular standard signaling pathway analysis methods in identifying altered signaling pathways. Furthermore, we show that the weighted genes importance could help us to detect the false positive genes in differentially expressed genes. We also show that the roles which we used to weight genes' importance are scientific.
